Generics Cos. Get More Freedom In High Court Patent Ruling
The U.S. Supreme Court's decision Thursday shutting down a patent case involving a generic heart drug that uses a so-called skinny label establishes a road map for generics companies to avoid...To view the full article, register now.
Already a subscriber? Click here to view full article